AI news ·
K Navigator sets new standard for AI-driven biomedical discovery
K Navigator is an AI co-pilot by Owkin that helps scientists explore multiomics data and cancer research with ease. It offers natural language interaction and access to vast biomedical databases.
K Navigator: an AI co-pilot transforming biomedical research
K Navigator is an AI-powered research co-pilot developed by Owkin, designed to accelerate biomedical discoveries by helping scientists explore complex data more efficiently. This platform integrates artificial intelligence with multiomics data and a user-friendly interface, enabling researchers to uncover biological insights faster than before.
A new era for biomedical discovery
K Navigator acts as an interactive research environment where scientists can test and refine hypotheses dynamically. It supports Owkin’s goal of building the first biological artificial superintelligence (BASI) by combining patient-level data with advanced reasoning tools. This approach helps to decode disease complexity and speeds up the development of medical breakthroughs.
Seamless exploration through natural language
The platform offers a natural language interface that simplifies research workflows. Scientists can engage in conversational interactions to visualize datasets, sharpen research questions, and discover new findings. K Navigator also supports comprehensive literature reviews across 26.5 million scientific articles and taps into 19 biomedical databases containing data from thousands of patients.
Exclusive access to spatial transcriptomics
A unique feature of K Navigator is its access to spatial multiomic data at single-cell resolution via MOSAIC Window, a subset of the largest spatial omics dataset in oncology. This data, sourced from leading academic institutions in Europe and the US, provides insights and precision unmatched by other AI tools. Performance benchmarks show K Navigator matches and in some cases exceeds leading models like OpenAI’s GPT-4 in detecting cancer-related patterns.
Free for academia, built for collaboration
K Navigator is offered free to academic researchers, supporting collaborative progress in biomedical science. Owkin works with global institutions to continually improve the platform. Upcoming features include:
- Seamless collaboration and result sharing
- Project organization tools
- Advanced histology functions such as filtering, grouping, heat mapping, and slide analysis
Later this year, Owkin plans to introduce K Pro, a version of the AI co-pilot aimed at pharmaceutical companies to assist in data exploration and drug development.
Expert praise from the scientific community
Dr. Ingo Ringshausen, Principal Investigator at University College London, highlighted K Navigator’s ease of use and its powerful multiomics data exploration capabilities. Dr. Cécile Alanio from Institut Curie emphasized how the tool empowers researchers to explore data independently while allowing bioinformaticians to focus on more complex analyses.
The vision: productising discovery
Owkin’s Co-founder and CEO, Thomas Clozel, explained the motivation behind K Navigator. Unlike chemistry, biology involves vast networks of genes, cells, and interactions that exceed unaided human comprehension. To advance medical research, it’s necessary to augment discovery processes by integrating large language models with extensive patient data. K Navigator aims to bridge this gap, moving closer to the true complexity of biology.
With K Navigator, Owkin sets a new benchmark for AI applications in life sciences by combining advanced technology with expert-driven research.